Prediction of short-term and long-term responses to cladribine in relapsing-remitting multiple sclerosis: a Danish nationwide real-world study.

Bramow S, Pontieri L, Heick A, Thormann A, Sejbæk T, Rasmussen P V, Weglewski A, Qadir S H, Romme Christensen J, Mærsk-Møller C, et al.

J Neurol. 2026 Oct 22; 273(11). PMID: 42911400. Abstract